News
G2Solutions: funding for innovation in single-cell genomics.
The G2Solutions project, led by Prof. Dr. Ir. Floris Foijer from the UMCG – ERIBA Research Institute, has received funding
21 October 2024
G2Solutions: funding for innovation in single-cell genomics.
The G2Solutions project, led by Prof. Dr. Ir. Floris Foijer from the UMCG – ERIBA Research Institute, has received funding
Publications – In collaboration with Pivot Park Screening Centre
Read our latest brochure with scientific publications we have contributed to. This provides valuable insights into the advancements and discoveries
The Minister of Healthcare at Pivot Park Screening Centre
On May 15th Pia Dijkstra, the Minister of Healthcare, visited the Pivot Park, where she also took a tour of
Dechering KJ, Timmerman M, Rensen K, Koolen KMJ, Honarnejad S, Vos MW, Huijs T, Henderson RWM, Chenu E, Laleu B,
Gising J, Honarnejad S, Bras M, Baillie GL, McElroy SP, Jones PS, Morrison A, Beveridge J, Hallberg M, Larhed M.
van Vlijmen H, Pannifer AD, Cochrane P, Basting D, Li VM, Engkvist O, Ortholand JY, Wagener M, Duffy J, Finsinger
High-Throughput Hit Discovery for Ion Channels and G Protein-Coupled Receptors
New approaches for hit discovery against Ion Channels and GPCRs using the Fluorescent Imaging Plate Reader (FLIPR) technology. Ion channels
Cost Effective Screening in 384 and 1536 well plates
Discover the advantages of utilizing both 384 and 1536 well plates in high-throughput screening (HTS). Learn how enhanced flexibility, cost-effectiveness, and adaptability can optimize your research efforts. Partner with us for streamlined data management and a competitive edge in drug discovery.
Fernández DI, Troitiño S, Sobota V, Tullemans BME, Zou J, van den Hurk H, García Á, HonarnejadS, Kuijpers MJE, Heemskerk
Label-Based and Label-Free Assays in Drug Discovery
Dive into the world of label-based and label-free assays with Pivot Park Screening Centre. Understand their pivotal role in drug discovery and how choosing the right partner can make all the difference.
Pivot Park Screening Centre (PPSC) has adopted Affinity Selection Mass Spectrometry (ASMS) workflow into its daily high-throughput screening (HTS) operations.
Exploring the world of early drug discovery through business travel
This blog delves into the world of business travel, specifically within the context of drug discovery, unraveling the intricacies of cultural nuances, the significance of personal interactions, and the divergent business cultures of the Dutch and the Japanese.
Pivot Park – Banting Building (RE600)
Kloosterstraat 9
5349 AB Oss
The Netherlands
Pivot Park Screening Centre
Building OP
Kloosterstraat 9
5349 AB Oss
The Netherlands
